Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Allen D. Judd"'
Autor:
J. Erika Haydu, Jenny S. Maron, Robert A. Redd, Kathleen M. E. Gallagher, Stephanie Fischinger, Jeffrey A. Barnes, Ephraim P. Hochberg, P. Connor Johnson, R. W. Takvorian, Katelin Katsis, Daneal Portman, Jade Ruiters, Sidney Sechio, Mary Devlin, Connor Regan, Kimberly G. Blumenthal, Aleena Banerji, Allen D. Judd, Krista J. Scorsune, Brianne M. McGree, Maryanne M. Sherburne, Julia M. Lynch, James I. Weitzman, Matthew Lei, Camille N. Kotton, Anand S. Dighe, Marcela V. Maus, Galit Alter, Jeremy S. Abramson, Jacob D. Soumerai
Publikováno v:
Blood Advances
Chronic lymphocytic leukemia (CLL), the most common leukemia worldwide, is associated with increased COVID-19 mortality. Previous studies suggest only a portion of vaccinated CLL patients develop severe acute respiratory syndrome coronavirus 2 (SARS-
Publikováno v:
Curr Opin Allergy Clin Immunol
Purpose of review Understand how the clinical history has been used to risk stratify patients reporting a beta-lactam allergy, both in clinical care pathways and predictive models. Recent findings Drug allergy clinical care pathways have emerged as a
Autor:
Kimberly G. Blumenthal, Tyler Harkness, Elizabeth J. Phillips, Allison Ramsey, Aleena Banerji, Upeka Samarakoon, Cosby Stone, Xiaoqing Fu, David A. Khan, Iris Otani, Carlos A. Camargo, Yuqing Zhang, Karen Donelan, Christian M. Mancini, Catherine M. Ahola, Allen D. Judd, Weaam Arman, Elizabeth Phillips, Kristina Williams, Ronald Eugene Osea, S. Shahzad Mustafa, Holly Blue, Autumn Guyer, David Khan
Publikováno v:
The journal of allergy and clinical immunology. In practice. 8(9)
Background Drug allergy is frequently reported, but uncommonly confirmed with diagnostic testing. Although drug allergy assessments can improve clinical care, patient concerns may impact the optimal diagnostic approach and/or the clinical effectivene